Free Trial

Sagimet Biosciences (SGMT) SEC Filings & 10K Form

Sagimet Biosciences logo
$4.12 +0.09 (+2.23%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$4.13 +0.01 (+0.24%)
As of 02/21/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sagimet Biosciences SEC Filings

DateFilerForm TypeView
02/14/2025
3:15 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:41 PM
Chauche Thierry (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:42 PM
Rozek Elizabeth (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:43 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:44 PM
Martins Eduardo Bruno (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
7:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:55 PM
Point72 Asset Management, L.P. (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
11/14/2024
3:27 PM
BAKER BROS. ADVISORS LP (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
11/14/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
11:15 PM
Sagimet Biosciences (Filer)
Form EFFECT
08/16/2024
3:53 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:27 PM
Sagimet Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/14/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
7:06 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:05 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:24 PM
Kemble George (Reporting)
Sagimet Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:05 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:05 PM
Rozek Elizabeth (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:06 PM
Martins Eduardo Bruno (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:26 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:07 AM
Sagimet Biosciences (Filer)
Form 8-K/A
06/06/2024
5:03 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
6:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
7:06 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
5:16 AM
Sagimet Biosciences (Filer)
Form DEF 14A
04/18/2024
5:19 AM
Sagimet Biosciences (Filer)
Form DEFA14A
04/18/2024
5:21 AM
Sagimet Biosciences (Filer)
Form ARS
04/03/2024
7:15 PM
Sagimet Biosciences (Issuer)
Walbert Timothy P (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
7:17 PM
Hoelscher Paul W. (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:19 PM
Sagimet Biosciences (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:13 PM
Hoelscher Paul W. (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2024
3:08 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
6:00 AM
Sagimet Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2024
5:37 AM
Sagimet Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
5:19 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SGMT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners